{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:49:16Z","timestamp":1784832556780,"version":"3.55.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,7,21]]},"DOI":"10.1001\/jama.2020.6611","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T16:33:39Z","timestamp":1595349219000},"page":"299","source":"Crossref","is-referenced-by-count":7,"title":["Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019"],"prefix":"10.1001","volume":"324","author":[{"given":"Jenny S.","family":"Guadamuz","sequence":"first","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima M.","family":"Qato","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"jld200033r3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pds.3762","article-title":"Patient understanding of drug risks: an evaluation of medication guide assessments.","volume":"24","author":"Knox","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"jld200033r4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40801-015-0042-5","article-title":"Physician and pharmacist understanding of the risk of urinary retention with retigabine (ezogabine): a REMS assessment survey.","volume":"2","author":"Ishihara","year":"2015","journal-title":"Drugs Real World Outcomes"},{"issue":"7","key":"jld200033r5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.2019.0235","article-title":"Assessment of the FDA Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl products.","volume":"321","author":"Rollman","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"jld200033r6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40264-016-0501-2","article-title":"Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for lenalidomide and thalidomide: patient comprehension and knowledge retention.","volume":"40","author":"Brandenburg","year":"2017","journal-title":"Drug Saf"},{"key":"jld200033r1","unstructured":"Risk Evaluation and Mitigation Strategies: REMS. US Food and Drug Administration website. Accessed September 9, 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/risk-evaluation-and-mitigation-strategies-rems"},{"key":"jld200033r2","unstructured":"FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety. US Department of Health and Human Services Office of Inspector General website. Published February 2013. Accessed February 1, 2020. https:\/\/oig.hhs.gov\/oei\/reports\/oei-04-11-00510.pdf"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2768453\/jama_guadamuz_2020_ld_200033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T16:33:44Z","timestamp":1595349224000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2768453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.6611","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,21]]}}}